Filter
360
Filtered Results: 360
Text search:
inactivated
vaccines
Featured
Recommendations
44
New Publications
105
Language
Document type
No document type
174
Guidelines
92
Studies & Reports
39
Manuals
20
Fact sheets
19
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
Global
11
Germany
11
India
11
South Africa
10
Nigeria
8
Pakistan
8
Latin America and the Carribbean
7
Sierra Leone
6
Syria
6
Philippines
6
Ethiopia
6
Nepal
5
Afghanistan
5
Tanzania
5
Kenya
4
Ukraine
4
Chile
4
Uganda
4
Namibia
4
Rwanda
3
Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Russia
3
Yemen
3
Ecuador
3
Myanmar / Burma
3
Malawi
2
Venezuela
2
Congo, Democratic Republic of
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Bangladesh
2
Papua New Guinea
2
Zambia
2
Liberia
2
North Macedonia
1
Colombia
1
Lesotho
1
Turkey
1
Gambia
1
China
1
Niger
1
Peru
1
Zimbabwe
1
Jordan
1
Paraguay
1
Bolivia
1
Argentina
1
Lebanon
1
Brazil
1
Egypt
1
Libya
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
110
Clinical Guidelines
49
Women & Child Health
17
Key Resources
9
Public Health
8
Pharmacy & Technologies
7
Capacity Building
1
Toolboxes
COVID-19
82
Polio
38
Rapid Response
25
TB
16
Ebola
16
Pharmacy
15
Refugee
14
HIV
11
NTDs
11
AMR
11
Conflict
8
Cholera
7
Zika
5
Natural Hazards
4
Planetary Health
3
Mental Health
2
Specific Hazards
1
Health Financing Toolbox
1
NCDs
1
Global Health Education
1
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
This report is the first of its kind. It brings together various data sets to present the current status of hand hygiene, highlight lagging progress, and call governments and supporting agencies to action, offering numerous inspiring examples of change.
During the COVID-19 pandemic, hand hygiene ...
The COVID-19 pandemic has led to large increases in healthcare waste, straining under resourced healthcare facilities and exacerbating environmental impacts from solid waste. This report quantifies the additional COVID-19 healthcare waste generated, describes current healthcare waste management syst...
Laboratory Biossafety Manual
Laboratory testing for the monkeypox virus
recommended
Any individual that meets the suspected case definition of monkeypox should be offered testing in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. Confirmation of monkeypox virus infection is based on nucleic acid amplification testing (NAAT), usi...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ...
The Country Cooperation Strategy is the World Health Organization (WHO)’s reference for country work guiding planning and resource allocation through alignment with national health priorities and harmonization with other development partners. It clarifies roles and functions of WHO in supporting t...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
The following information provides guidance to health care providers attending to the medical needs of HIV-infected adults (including pregnant women) or children displaced from disaster areas who have not yet secured HIV care in the areas where they have relocated.
(*)
- HHS Panel on Antiretrov...
6th edition
